GlassScriptPhysician profile
Ajay Sharma
NPI 1902483027
$2,206.41
in general payments reported to CMS, 2019-2025
10 companies · $368 in 2025
The $368 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $120 · 2023: $645 · 2024: $1,073 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,006 · Education: $80.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,005.79 |
| Education | $80.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $596.70 | 2023-2025 | |
| Janssen Biotech, INC. | $253.94 | 2024 | Tremfya |
| Lilly USA, LLC | $234.56 | 2024 | Olumiant, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $210.23 | 2023-2025 | Spevigo |
| Regeneron Healthcare Solutions, INC. | $201.26 | 2023 | Libtayo, Dupixent |
| Galderma Laboratories, L.P. | $177.91 | 2025 | |
| Dermavant Sciences, INC. | $142.97 | 2023-2024 | Vtama |
| Pfizer INC. | $135.00 | 2024 | |
| Ucb, INC. | $134.08 | 2024 | Bimzelx |
| Amgen INC. | $119.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.